Nilontinib induced keratosis pilaris atrophicans

Shilpi Khetarpal, Apra Sood, Steven D. Billings

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Keratosis pilaris (KP) is a disorder of follicular keratinization that is characterized by keratin plugs in the hair follicles with surrounding erythema. A 46-year-old man with chronic myelogenous leukemia (CML) was started on nilotinib, a second generation tyrosine kinase inhibitor (TKI). Two months later the patient noticed red bumps on the skin and patchy hair loss on the arms, chest, shoulders, back, and legs. Cutaneous reactions to nilotinib are the most frequent non-hematologic adverse effects reported. However, it is important to distinguish KP-like eruptions from more severe drug hypersensitivity eruptions, which can necessitate discontinuing the medication. Also, it is important to classify the cutaneous eruptions in patients on TKI according to the morphology instead of labeling them all as “chemotherapy eruption” to be able to better manage these adverse effects.

Original languageEnglish (US)
Article number8
JournalDermatology Online Journal
Volume22
Issue number8
StatePublished - Jan 1 2016
Externally publishedYes

Keywords

  • Keratosis pilaris atrophicans
  • Nilontinib
  • Tyrosine kinase inhibitors

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Nilontinib induced keratosis pilaris atrophicans'. Together they form a unique fingerprint.

  • Cite this

    Khetarpal, S., Sood, A., & Billings, S. D. (2016). Nilontinib induced keratosis pilaris atrophicans. Dermatology Online Journal, 22(8), [8].